Guidelines

Guidelines

EULAR keeps csDMARDs as top PsA drugs

EULAR’s revised psoriatic arthritis recommendations retain methotrexate and other csDMARDS as first-line treatment over TNF inhibitors.

Guidelines

Are guidelines relevant?

RCTs represent a very special subset of any disease process but they are the best we can do.

Pages